Altered expression of the class I and II HDAC enzymes is observed in solid tumors including NB, medulloblastoma, lung adenocarcinoma, renal, bladder, breast, and various cancers of the gastrointestinal and reproductive tracts [13]. This evidence concerns the gene HDAC9 and neuroblastoma.